• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection and Management in Pharmacovigilance
  • News
  • Opinion
  • About
  • Glossary

Drug Substance (DS)

January 5, 2024 by Jose Rossello

A drug substance, also known as an active pharmaceutical ingredient (API), is the main component within a medication that is biologically active and is intended to have a therapeutic effect. It’s the part of any drug that produces the intended effects, such as pain relief, reduction of inflammation, or combating bacterial infections.

Characteristics of a Drug Substance:

  1. Biological Activity: The drug substance is specifically chosen for its ability to interact with the body in a way that will produce a desired therapeutic effect.
  2. Purity: Drug substances are required to be highly pure to ensure safety and efficacy. The purity is closely regulated and monitored.
  3. Quality Control: The quality of the drug substance is critical. It is subject to rigorous testing and quality control measures during manufacturing to ensure it meets the required standards.
  4. Synthesis or Extraction: Drug substances can be synthesized chemically, extracted from natural sources (like plants or animals), or produced biotechnologically (such as in the case of many biologic drugs).
  5. Formulation: Once the drug substance is developed, it must be formulated into a drug product, like a tablet, injection, or ointment. This process involves combining the drug substance with other ingredients (excipients) to ensure it can be administered effectively and stored safely.
  6. Regulatory Approval: Drug substances must be approved by regulatory agencies, like the FDA in the United States or the EMA in the European Union, based on evidence of their safety, efficacy, and quality.

Drug Substance vs. Drug Product:

  • Drug Substance (API): The active ingredient that is intended to exert the therapeutic effect.
  • Drug Product: The final form of the medication that contains the drug substance along with other ingredients (excipients). This could be tablets, capsules, injectable solutions, etc.

Role in Drug Development:

  • Discovery and Development: The discovery of a new drug substance is the initial step in the development of a new medication. This involves extensive research, testing, and clinical trials.
  • Scale-Up and Manufacturing: Once a drug substance has been discovered and approved, it must be produced on a large scale. This requires a careful balance of maintaining purity and efficacy while ensuring cost-effectiveness.

Importance:

The drug substance is critical in determining the effectiveness and safety of the medication. It’s the core around which drug development and pharmaceutical manufacturing revolve, making it a key focus of regulatory scrutiny and scientific innovation in the pharmaceutical industry.

Primary Sidebar

Subscribe in a reader

Search Website

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Signal Analytics Technology in Pharmacovigilance

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, … [Read More...] about Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

8 Common FDA Applications for Drugs & Biologics

The U.S. Food and Drug Administration (FDA) has several types of applications … [Read More...] about 8 Common FDA Applications for Drugs & Biologics

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Investigational New Drug (IND) applications represent a critical stage in the … [Read More...] about Key IND Enabling Studies: Navigating Preclinical Development Regulations

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field … [Read More...] about Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Regulatory authorities in the pharmaceutical industry have established standards … [Read More...] about Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

In the realm of patient safety and pharmacovigilance, statistical signal … [Read More...] about Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Pharmacovigilance signal detection software plays a crucial role in … [Read More...] about Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured … [Read More...] about What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Drug safety and pharmacovigilance are crucial aspects of public … [Read More...] about Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

he Development Safety Update Report (DSUR) is a crucial document that serves as … [Read More...] about Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

  • What is a DSUR (Development Safety Update Report)? An Essential Guide for Clinical Research
  • What is a BLA (Biologics License Application)? Essential Guide for Professionals
  • What is a PADER? – Periodic Adverse Drug Experience Report Explained

RSS ICH News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS From Nature journal

  • Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus
  • Designing and characterizing first Iranian study evaluating serum levels of lithium in patients for population pharmacokinetics (FIRELOLIPOP): baseline and first report
  • Application of new approach methodologies for nonclinical safety assessment of drug candidates
  • FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury
  • Galleria mellonella as a drug discovery model to study oxidative stress

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in